Bausch + Lomb Income After Taxes 2021-2025 | BLCO
Bausch + Lomb income after taxes from 2021 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Bausch + Lomb Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $-305 |
| 2023 | $-248 |
| 2022 | $15 |
| 2021 | $193 |
| 2020 | $-17 |
| Bausch + Lomb Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-211 |
| 2024-12-31 | $-2 |
| 2024-09-30 | $8 |
| 2024-06-30 | $-148 |
| 2024-03-31 | $-163 |
| 2023-12-31 | $-51 |
| 2023-09-30 | $-80 |
| 2023-06-30 | $-29 |
| 2023-03-31 | $-88 |
| 2022-12-31 | |
| 2022-09-30 | $-15 |
| 2022-06-30 | $7 |
| 2022-03-31 | $23 |
| 2021-12-31 | $54 |
| 2021-09-30 | $63 |
| 2021-06-30 | $46 |
| 2021-03-31 | $30 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $4.386B | $4.791B |
| Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.275B | 26.68 |
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Elevance Health (ELV) | United States | $86.192B | 11.12 |
| Cencora (COR) | United States | $58.035B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.934B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| ICON (ICLR) | Ireland | $11.674B | 10.85 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Caris Life Sciences,�Inc (CAI) | $6.821B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| Premier (PINC) | United States | $1.779B | 13.51 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |